Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney Cancer
NCT00003656
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class
Conditions
Kidney Cancer
Interventions
BIOLOGICAL:
recombinant interferon alfa
DRUG:
tretinoin liposome
Sponsor
Weill Medical College of Cornell University